Changes in Cell Shape Correlate with Collagenase Gene Expression in Rabbit Synovial Fibroblasts
Overview
Authors
Affiliations
Induction of the neutral proteinase, collagenase, is a marker for a specific switch in gene expression observed in rabbit synovial fibroblasts. A variety of agents, including 12-O-tetradecanoylphorbol-13-acetate, cytochalasins B and D, trypsin, chymotrypsin, poly(2-hydroxyethylmethacrylate), and trifluoperazine induced this change in gene expression. Induction of collagenase by these agents was always correlated with a marked alteration in cell morphology, although the cells remained adherent to the culture dishes. The amount of collagenase induced was positively correlated with the degree of shape change produced by a given concentration and, to some extent, with the duration of treatment. Altered cell morphology was required only during the first few hours of treatment with inducing agents; after this time collagenase synthesis continued for up to 6 d even when agents were removed and normal flattened cell morphology was regained. All agents that altered cell morphology also produced a characteristic switch in protein secretion phenotype, characterized by the induction of procollagenase (Mr 53,000 and 57,000) and a neutral metalloproteinase (Mr 51,000), which accounted for approximately 25% and 15% of the protein secreted, respectively. Secretion of another neutral proteinase, plasminogen activator, did not correlate with increased collagenase secretion. In contrast, synthesis and secretion of a number of other polypeptides, including the extracellular matrix proteins, collagen and fibronectin, were concomitantly decreased. That changes in cell shape correlated with a program of gene expression manifested by both degradation and synthesis of extracellular macromolecules may have broad implications in development, repair, and pathologic conditions.
Minimally invasive therapies for Peyronie's disease: the current state of the art.
Farrell M, Ziegelmann M, Levine L Transl Androl Urol. 2020; 9(Suppl 2):S269-S283.
PMID: 32257868 PMC: 7108992. DOI: 10.21037/tau.2019.08.06.
Peyronie's disease: contemporary review of non-surgical treatment.
Levine L Transl Androl Urol. 2016; 2(1):39-44.
PMID: 26816722 PMC: 4708604. DOI: 10.3978/j.issn.2223-4683.2013.01.01.
Peyronie's disease: A contemporary review of non-surgical treatment.
Levine L Arab J Urol. 2015; 11(3):278-83.
PMID: 26558093 PMC: 4442988. DOI: 10.1016/j.aju.2013.03.008.
Hensler D, Illingworth K, Musahl V, Working Z, Kobayashi T, Miyawaki M Knee Surg Sports Traumatol Arthrosc. 2014; 23(3):669-79.
PMID: 25326761 DOI: 10.1007/s00167-014-3380-z.
Baker N, Sharpe P, Culley K, Otero M, Bevan D, Newham P Arthritis Rheum. 2012; 64(7):2289-99.
PMID: 22294415 PMC: 3366172. DOI: 10.1002/art.34411.